Key Points
- CEO Catherine Corrigan sold 3,912 Exponent shares on March 16 at an average of $67.49 (~$264,021) under a pre‑arranged Rule 10b5‑1 plan, reducing her stake by 3.69% to 101,981 shares; she executed similar sales on Feb. 17 and Apr. 15.
- Exponent beat quarterly expectations with $0.49 EPS and $147.43M revenue, and raised its quarterly dividend to $0.31 (annualized $1.24, ~1.8% yield), while analysts hold a mixed but moderately positive outlook (average target ~$90).
Exponent, Inc. (NASDAQ:EXPO - Get Free Report) CEO Catherine Corrigan sold 3,912 shares of Exponent stock in a transaction that occurred on Monday, March 16th. The shares were sold at an average price of $67.49, for a total value of $264,020.88. Following the completion of the sale, the chief executive officer owned 101,981 shares in the company, valued at approximately $6,882,697.69. This trade represents a 3.69% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Catherine Corrigan also recently made the following trade(s):
- On Wednesday, April 15th, Catherine Corrigan sold 3,909 shares of Exponent stock. The shares were sold at an average price of $67.70, for a total transaction of $264,639.30.
- On Tuesday, February 17th, Catherine Corrigan sold 3,920 shares of Exponent stock. The stock was sold at an average price of $67.15, for a total transaction of $263,228.00.
Exponent Trading Down 0.2%
EXPO stock opened at $68.12 on Friday. The firm has a 50 day moving average of $68.87 and a 200-day moving average of $70.31. The company has a market cap of $3.35 billion, a price-to-earnings ratio of 32.75 and a beta of 0.80. Exponent, Inc. has a 12-month low of $63.25 and a 12-month high of $83.92.
Exponent (NASDAQ:EXPO - Get Free Report) last released its quarterly earnings data on Thursday, February 5th. The business services provider reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.47 by $0.02. Exponent had a return on equity of 25.51% and a net margin of 18.21%.The firm had revenue of $147.43 million during the quarter, compared to the consensus estimate of $128.48 million. During the same period last year, the business posted $0.46 EPS. Exponent's quarterly revenue was up 4.5% on a year-over-year basis. Sell-side analysts forecast that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.
Exponent Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Friday, March 6th were given a dividend of $0.31 per share. The ex-dividend date was Friday, March 6th. This is an increase from Exponent's previous quarterly dividend of $0.30. This represents a $1.24 dividend on an annualized basis and a yield of 1.8%. Exponent's dividend payout ratio (DPR) is presently 59.62%.
Hedge Funds Weigh In On Exponent
Several large investors have recently added to or reduced their stakes in the business. Hantz Financial Services Inc. increased its stake in shares of Exponent by 97.0% during the 3rd quarter. Hantz Financial Services Inc. now owns 396 shares of the business services provider's stock valued at $28,000 after acquiring an additional 195 shares during the last quarter. Aster Capital Management DIFC Ltd purchased a new stake in shares of Exponent during the 3rd quarter valued at $33,000. Allworth Financial LP boosted its holdings in Exponent by 86.1% in the fourth quarter. Allworth Financial LP now owns 469 shares of the business services provider's stock valued at $33,000 after acquiring an additional 217 shares during the last quarter. Winnow Wealth LLC purchased a new position in shares of Exponent in the 3rd quarter worth about $34,000. Finally, Pilgrim Partners Asia Pte Ltd acquired a new stake in Exponent during the 3rd quarter worth approximately $38,000. 92.37% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
EXPO has been the subject of several research reports. UBS Group restated a "neutral" rating and set a $85.00 price objective on shares of Exponent in a research report on Monday, February 9th. Weiss Ratings reissued a "hold (c-)" rating on shares of Exponent in a research note on Thursday, January 22nd. Finally, JPMorgan Chase & Co. cut their price objective on shares of Exponent from $100.00 to $95.00 and set an "overweight" rating for the company in a research report on Thursday, March 26th. Two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $90.00.
Check Out Our Latest Analysis on Exponent
About Exponent
(
Get Free Report)
Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company's expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.
Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
